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DNB: a partial D with anti-D frequent in Central Europe
Franz F. Wagner, Nicole I. Eicher, Jan R. Jørgensen, Cornelie B. Lonicer, and WillyA. Flegel
To improve routine D typing and deﬁne
transfusion strategy, it is important to
establish the frequency of partial D al-
leles and their susceptibility to anti-D
alloimmunization due to transfusion or
pregnancy. We identiﬁed the partial D
DNB that was caused by an RHD(G355S)
allele associated with a CDe haplotype
and whose phenotype presented a nor-
mal D in routine typing. The antigen den-
sity was about 6000 D antigens per red
blood cell, and the Rhesus index was
0.02.Fiveanti-Dimmunizationeventswith
allo–anti-D titers up to 128 were ob-
served. Twelve carriers of DNB were
whites of Central Europe; the only Danish
proband had Austrian ancestry. DNB was
the most frequent partial D recognized so
far in whites, occurring with frequencies
of up to 1:292 in Switzerland. DNB was
the underlying partial D phenotype in a
relevant fraction of anti-D immunizations
occurring in whites. (Blood. 2002;100:
2253-2256)
© 2002 by TheAmerican Society of Hematology
Introduction
Anti-D immunizations may occur in “partial D” carriers. This
designation relates to more than 30 alleles differing in molecular
structure, phenotype, population frequency, and lenience to anti-D
production.1 The molecular bases were gene conversions,2 single
missense mutations in the exofacial protein segments,3 and mul-
tiple missense mutations dispersed throughout the RhD protein.4A
partial D needs to be considered for transfusion strategies if its
carriers are frequent, easily anti-D immunized, and likely to receive
D-positive units in the case of transfusion. D category VI 5 is the
classical example. In several countries, typing methods6 were
introduced that assured D-negative transfusion and anti-D
prophylaxis for DVI mothers to prevent anti-D immunizations.
Despite the large number of known partial D alleles, a relevant
portion of anti-D immunizations is still occurring in individuals
who did not carry any known partial D.7-9Thus, the characteriza-
tion of the unknown alleles underlying such case reports is
remaining important.
Study design
Blood samples with anti-D
Two D-positive samples (RIR-2 from Bern, Switzerland; RIR-3 from
Bavaria, Germany) with anti-D were referred to our laboratory to
elucidate the cause of anti-D immunization. Later, 1 additional blood
sample (RIR-41 from Denmark) and 2 DNA samples (RIR-7, RIR-8
from Austria) were referred to the Rhesus Immunization Registry (RIR)
because of anti-D in these D-positive probands. The Danish proband
RIR-41 had anAustrian grandfather.
RHD nucleotide sequencing
DNA was handled as described previously.10 The 10 RHD exons were
sequenced by an RHD allele–speciﬁc method11 in the 2 index samples
(RIR-2, RIR-3). In the remaining samples, exon 7 was sequenced only.
PCR-SSP
Apolymerase chain reaction with sequence-speciﬁc priming (PCR-SSP) to
conﬁrm or detect the 1063GA substitution in DNB was devised as
modular extension of a PCR-SSP system previously developed for RHD
typing.10,12 Speciﬁc primers were re77 (TCTCCACAGCTCCATCATGGG)
and DNBb (CAGTGACCCACATGCCATTACT) at a concentration of 3.5
mol; HGH control primers were used at 0.75 mol.
Immunohematology
Routine D typing was done in tube tests using commercial monoclonal
anti-D (Seraclone anti-D 226, clone BS226; and Seraclone anti-D [232],
clone BS232; Biotest, Dreieich, Germany; and ImmuClone anti-Dfast,
clone D1-4E11; and ImmuClone anti-Drapid, clone RUM-1; Immucor,
Norcross, GA). A commercial panel of monoclonal anti-D (D-Screen;
Diagast, Loos, France) was tested in gel matrix technique (LISS-Coombs
37°C, DiaMed-ID Micro Typing System; DiaMed, Cressier sur Morat,
Switzerland). D epitopes were determined by agglutination, and antigen
density and Rhesus index were determined by ﬂow cytometry as previously
described.13 DIV type III 13 and DNU14 controls derived from donors in
Baden-Wu ¨rttemberg, Germany.
Population screens for DNB
Ethylenediaminetetraacetic acid (EDTA)– or citrate-anticoagulated blood
samples were collected from blood donors in Baden-Wu ¨rttemberg (Ger-
many, 1118 donors of CcDee phenotype, 1010 donors of ccDEe phenotype),
Ticino (Italian-speaking Switzerland, 500 D-positive donors), Bern region
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Denmark (768 donors of CcDee phenotype). The donors were tested with
the immunoglobulin G (IgG) monoclonal anti-D LOR17-6C7 (Germany
and Denmark) or HIRO-7 (Switzerland).15 Suspected DNB samples were
conﬁrmed by sequencing of exon 7 or by PCR-SSP. Haplotype frequencies
used for calculation of DNB allele frequencies were CDe 0.431, cde 0.394,
cDe 0.021, and Cde 0.011 in Germans16; 0.4236, 0.3792, 0.0145, and
0.0059 in Danes17; and 0.4442, 0.3617, 0.0232, 0.0113, and cdE 0.049 in
Swiss.17 Phenotype frequencies for CcDee were compared using the Fisher
exact test for a 4  2 contingency table; for this calculation the 500
D-positivesamplesinTicinowereinferredtocomprise187CcDeesamples.
Nomenclature
The name DNB derived from DNU-like and Bayern (Bavaria, Germany) or
Bern, because DNB was similar to DNU,14 whose point mutations were
closely adjacent.
Results and discussion
Molecular structure
The molecular structure of 2 D-positive samples with anti-D
(RIR-2, RIR-3) was determined by RHD-speciﬁc sequencing from
genomic DNA. In RHD exon 7, a single G to A exchange at
position 1063 was detected that resulted in a Gly to Ser substitution
at codon 355. The affected amino acid was located in the exofacial
loop 6, adjacent to the mutations observed in DII (Ala to Asp at
position 354)14 and DNU (Gly to Arg at position 353).14 The
nucleic acid and amino acid sequence data were deposited in
EMBL/GenBank/DDBJ under accession numberAJ417868.
Immunohematology
In routine D typing, both DNB samples typed as CcDee without
noticeable weakening of the antigen D.All 9 monoclonal anti-Ds of
a commercial partial D classiﬁcation kit (D-Screen) were reactive.
An antigen density of 5908 antigens per cell and a Rhesus index13,18
(RI) of 0.02 were determined in RIR-2. These results were
comparable to those obtained with a DNU sample (8073 antigens
per cell, RI 0.06) and a CcDee DIV type 3 sample (4544 antigens
per cell, RI 0). The D epitope pattern was determined for both
index samples and was unique (Table 1): 6 of 83 anti-Ds tested
did not agglutinate DNB, indicating a loss of epitopes epD6 and
epD31 as well as part of epD18 and epD23. The crossmatch with
DNU red cells was faintly positive; there are no DII red cells
available anymore.
Population frequencies
We screened random samples of CcDee blood donors in 4
European populations (Table 2).With the exception of Danes, DNB
was found frequently. The highest frequency was observed in the
Ticino population. DNB was the most frequent partial D in whites
described so far; its frequency even exceeded that of DVII.19
Further testing of other populations may be of potential beneﬁt.
Including the probands with anti-D, we presented 12 unrelated
carriers of DNB who were whites of Central Europe; the only
Danish proband had an Austrian grandfather, from whom he may
have inherited the DNB allele. All DNB probands were of CcDee
phenotype. The CDe haplotype association was further corrobo-
rated by testing the parents of the Danish proband RIR-41, who
inherited his DNB allele from his CCDee father.
Anti-D immunization
Including the 2 index probands, 5 cases of allo–anti-D immuniza-
tion submitted to the Rhesus Immunization Registry occurred in
DNB probands (RIR-2, RIR-3, RIR-7, RIR-8, and RIR-41).20
These cases represented a sizable fraction of the 32 conﬁrmed
allo–anti-D immunizations reported to this registry until February
2002. Although any Rhesus-positive blood sample with anti-D—
with or without known Rhesus variant—may be sent to the registry
for analysis, no other RHD allele was involved in a similar number
of cases. Two additional carriers of DNB with anti-D were from
Slovakia (Dr Martin Pisacka, personal communication, 1999) and
from Germany (submitted as RIR-49 after we had ﬁnished the
data analysis).
Anti-D titers ranged from 4 to 128, indicating that DNB carriers
were generally able to produce strong anti-D. However, no clinical
data like signs of transfusion reactions or hemolytic disease of the
newborn were reported. In concordance with the assumption that
Table 1. Reactivity patterns of monoclonal anti-D
Pattern*
Anti-D
tested, n†
Partial D
1-9 1-37 DNB‡ DII§ DNU‡ DIV type 3‡
111  
122  
232  
241  
353  
461  
572  
51 0 4  
51 1 1  
6/7 12 4  
6/7 13 6  
6/7 15/16 8  
4  
6/7 17 8  
6/7 18 6  
1  
6/7 20/21 3  
1  
82 2 2  
92 3 3  
2  
2  
N/A 31 2  
N/A 32 1  
N/A 33 1  
N/A 34 1  
N/A 35 1  
N/A 36 3  
1  
N/A 37 5  
N/A indicates not applicable; , a normal or weak positive result; and ,a
negative result.
*Pattern is as described previously by Lomas et al24 (1-9) and Scott21 (1-37).
†A complete listing of the antibodies was published previously13 (Table 2). The
following antibodies failed to agglutinate DNB: LOR17-6C7 (epD6), P3F20 (epD18),
HIRO-7, HIRO-8 (epD23), NAU6-1G6, and NOU (epD31). In addition, the reactivity of
the following anti-Ds differed from that of the majority assigned to the respective
epitope: D-90/7, SAL20-12D5, LHM50/2B, BIRMA-DG3 (epD15/16), as well as
VOL-3F6 (epD20/21) did not agglutinate DIV type 3; LHM77/64, BIRMA-D6 (epD23),
and NAU6-4D5 (epD36) did not agglutinate DNU.
‡The DNB pattern was established with samples RIR-2 and RIR-3 and the DNU
pattern with red cells of the original DNU donor.14 The DIV type 3 data are a
reevaluation of the original pattern using a CcDee DIV type 3 donor from our local
population.
§The results depicted for D category II were determined by Scott21 and are
shown for comparison.
2254 WAGNER et al BLOOD, 15 SEPTEMBER 2002 VOLUME 100, NUMBER 6
For personal use only. on November 3, 2014.  by guest    www.bloodjournal.org From these anti-Ds were triggered by transfusion or pregnancies, 4 of the
probands were female; the male and at least 2 of the female
probands were transfused prior to the detection of the anti-D. The
anti-D was still detectable up to 8 years following the latest
possible anti-D immunization event.
Impact on typing strategies
The repeated observations of anti-D immunizations probably
reﬂected the combination of a high population frequency with a
phenotype that triggered D-positive transfusions and with a
moderate anti-D immunization potential. Hence, we recom-
mended D-negative transfusions if a recipient is known to carry
a DNB phenotype.
Aserologic recognition of DNB would be demanding because it
has a normal antigen density and is agglutinated by most anti-Ds,
including almost all commercial anti-D typing reagents. All tested
high-afﬁnity monoclonal IgM anti-Ds that did not bind DVI but
that agglutinated most weak D phenotypes13,21 agglutinated DNB
also (Table 1). Therefore, a serologic strategy for detecting DNB
would have to rely on a separate anti-D especially introduced to
discriminate DNB from normal D. By careful selection of this third
antibody (eg, HIRO-7 or HIRO-8), the strategy could be tuned to
discriminate also DII, DIV, and R0
Har from normal D.21 Such a major
change in D typing would be costly and might induce uncertainties
that outweigh the beneﬁt by far. The anti-D immunization risk in
DNB carriers may safely be estimated to be lower than 1% per
D-positive transfusion. This immunization index was less than
known for anti-K and anti-c 22 but may be comparable to that of
anti-Fy(a) and anti-Jk(a).
Genotyping strategies are increasingly utilized for blood group-
ing23 and may be devised to meet predeﬁned speciﬁcity criteria. For
example, RHD PCR in whites may be tuned to a speciﬁcity of
greater 0.9999 and allows the identiﬁcation of D-positive units
missed by routine serology.10 Likewise, DNB or DIIIa alleles may
be detected speciﬁcally without any limitations imposed by the
lack of suitable monoclonal anti-D. Because the frequency of
partial D with relevant anti-D immunization risk is low in whites,
their D-negative transfusion would not compromise the D-negative
blood supply. Hence, a speciﬁc recognition and D-negative transfu-
sion strategy for DNB may be perceived advantageous and become
feasible with genotyping strategies in the future.
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